| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/SMJ.0B013E3181FAE4E8 |
| P698 | PubMed publication ID | 21057383 |
| P2093 | author name string | Manoj Kumar | |
| Jorge L. Herrera | |||
| P2860 | cites work | Taiwan yi xue hui za zhi | Q27711485 |
| NIH consensus and state-of-the-science statements | Q27720734 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Diagnosis, management, and treatment of hepatitis C | Q29620656 | ||
| Consensus statement on the role of hepatitis A vaccination in patients with chronic liver disease | Q33950199 | ||
| What did we learn from the Shanghai hepatitis A epidemic? | Q33952213 | ||
| Efficacy of a high and accelerated dose of hepatitis B vaccine in alcoholic patients: a randomized clinical trial | Q34065241 | ||
| Cost-effectiveness of preimmunization hepatitis B screening in high-risk adolescents | Q34754669 | ||
| Review article: hepatitis vaccination in patients with chronic liver disease | Q35714136 | ||
| Screening for hepatitis A and B antibodies in patients with chronic liver disease | Q36306893 | ||
| Efficacy of repeated high-dose hepatitis B vaccine (80 microg) in patients with chronic liver disease | Q36447512 | ||
| The clinical course of acute type A hepatitis in chronic HBsAg carriers--a report of 3 cases | Q39112716 | ||
| Serologic markers of hepatitis B virus infection | Q39589282 | ||
| Vaccines to prevent viral hepatitis | Q41300062 | ||
| A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination | Q41759700 | ||
| Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease | Q42673894 | ||
| Hepatitis B vaccine efficacy in patients with chronic liver disease by hepatitis C virus | Q42990302 | ||
| Virologic and clinical expressions of reciprocal inhibitory effect of hepatitis B, C, and delta viruses in patients with chronic hepatitis | Q43000718 | ||
| Hepatitis C virus RNA and hepatitis B virus DNA in serum and liver of patients with fulminant hepatitis. | Q43048468 | ||
| Hepatitis A infection in chronic carriers of hepatitis B virus. | Q43502063 | ||
| Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C. | Q44072943 | ||
| Immunogenicity of hepatitis A vaccine in decompensated liver disease | Q44194285 | ||
| Susceptibility to hepatitis A in patients with chronic liver disease due to hepatitis C virus infection: missed opportunities for vaccination. | Q45425549 | ||
| Concurrent hepatitis B and C virus infection and risk of hepatocellular carcinoma in cirrhosis. A prospective study | Q45783032 | ||
| Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations | Q45788736 | ||
| Can patients awaiting liver transplantation elicit an immune response to the hepatitis A vaccine? | Q54202915 | ||
| Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C | Q60364371 | ||
| Immune response to anti-HBV vaccination: study of conditioning factors | Q67989827 | ||
| Acute type A hepatitis in three patients with chronic HBV infection | Q71791306 | ||
| Vaccination against hepatitis B in patients with chronic liver disease awaiting liver transplantation | Q73166025 | ||
| Safety and immunogenicity of inactivated hepatitis A vaccine in patients with chronic liver disease | Q73406638 | ||
| Immunogenicity of hepatitis A vaccination in decompensated cirrhotic patients | Q74115947 | ||
| Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? | Q74359348 | ||
| Prescreening versus empirical immunization for hepatitis A in patients with chronic liver disease: a prospective cost analysis | Q74503051 | ||
| The effect of high dose and short interval HBV vaccination in individuals with chronic hepatitis C | Q77694208 | ||
| Hepatitis B vaccines | Q80853921 | ||
| Double infections with hepatitis A and B viruses | Q93675095 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chronic liver disease | Q5113984 |
| P304 | page(s) | 1223-1231 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Southern Medical Journal | Q7570126 |
| P1476 | title | Importance of hepatitis vaccination in patients with chronic liver disease | |
| Importance of Hepatitis Vaccination in Patients with Chronic Liver Disease | |||
| P478 | volume | 103 |
| Q84498971 | Changes in hepatitis A and B vaccination rates in adult patients with chronic liver diseases and diabetes in the U.S. population |
| Q35747360 | Hepatitis A Virus among Drug Users and the Role of Vaccination: A Review |
| Q37694885 | Immunogenicity and safety of hepatitis E vaccine in healthy hepatitis B surface antigen positive adults |
| Q40063920 | Knowledge, attitudes and barriers regarding vaccination against hepatitis A and B in patients with chronic hepatitis C virus infection: a survey of family medicine and internal medicine physicians in the United States. |
| Q38260704 | Relative effects of heavy alcohol use and hepatitis C in decompensated chronic liver disease in a hospital inpatient population |
| Q46121018 | Vaccine induced Hepatitis A and B protection in children at risk for cystic fibrosis associated liver disease. |
Search more.